Alkalinized Lidocaine in the ETT Cuff: Why the Wait, and Does It Actually Work?

This is correct, standard pharmacokinetics — not a novel claim, but worth having the reasoning spelled out.

The ETT cuff membrane (typically PVC) is semi-permeable and relatively impermeable to the ionized (charged) form of lidocaine, but comparatively more permeable to the unionized, lipid-soluble form. Lidocaine has a pKa around 7.9; at physiological pH, only a small fraction exists unionized. Adding sodium bicarbonate raises the pH of the intracuff solution, shifting the Henderson-Hasselbalch equilibrium toward more unionized lidocaine, which diffuses across the cuff membrane more readily and provides continuous topical tracheal mucosal anesthesia. This is why there's a genuine delay after filling the cuff before the anesthetic effect is established — trans-cuff diffusion takes time, and it's the correct explanation for that lag, not an error.

An evidence-based review pooling three RCTs and three systematic meta-analyses (2,337 patients total) rated all included studies Level 1, Grade A — clinically solid evidence specifically for reduced postoperative sore throat, reduced postextubation cough, and reduced hoarseness. The one outcome that doesn't move much is dysphagia, where the evidence is weak to absent.

A secondary, less-discussed benefit that the post correctly includes.

Nitrous oxide diffuses into air-filled ETT cuffs faster than the trapped air/nitrogen diffuses out, progressively raising cuff pressure over the course of an N2O-containing anesthetic — a real, published phenomenon (Tu et al., Anaesthesia) that can contribute to tracheal mucosal injury from cuff overpressure. Filling the cuff with a liquid (lidocaine solution) instead of a gas avoids this specific mechanism, since there's no gas-phase compartment for N2O to diffuse into.

Both practical notes in the post match standard technique.

• The commonly studied preparation — 2% lignocaine 19 mL + 8.4% sodium bicarbonate 1 mL (19:1 ratio, 20 mL total) — matches the mixture used across the majority of trials in this literature (e.g., the smokers' trial specifically used 2% lidocaine + 8.4% NaHCO3).
• The post's caution against relying on a fixed inflation volume, and instead measuring actual cuff pressure with a manometer after achieving an adequate seal, is correct and standard airway-safety practice independent of what's used to fill the cuff.

Every claim in the source post checks out: the pharmacokinetic mechanism explaining the delay before effect, the N2O cuff-pressure avoidance, the 19:1 dosing ratio, and the caution about manometer-based (not volume-based) cuff inflation. What's worth adding is that this isn't just theoretically sound — it's backed by Level 1, Grade A evidence across multiple meta-analyses specifically for reduced postoperative sore throat and extubation cough, with the sore throat effect size (RR ~0.33–0.46) large enough to matter clinically. The one outcome it doesn't meaningfully move is dysphagia.

• the_anaesthesialife. Original post on alkalinized lidocaine ETT cuff mechanism. — read the original post before relying on this summary.
• Tanaka Y, et al. Intravenous versus intracuff alkalinized lidocaine to prevent postoperative sore throat: a prospective randomized controlled trial. Pan Afr Med J. 2024.
• Effect of Intracuff Lidocaine on Postoperative Sore Throat and the Emergence Phenomenon: A Systematic Review and Meta-Analysis of RCTs. PLOS One. 2015;10(8):e0136184.
• Intracuff Lidocaine and Postoperative Throat Mucosal Injuries: An Evidence-based Review. J Perianesth Nurs. 2024.
• Estebe JP, et al. The effect of intracuff alkalinized 2% lidocaine on emergence coughing, sore throat, and hoarseness in smokers. Rev Assoc Med Bras. 2012;58(2):248–253.
• Peng F, Wang M, Yang H, Yang X, Long M. Efficacy of intracuff lidocaine in reducing coughing on tube: a systematic review and meta-analysis. J Int Med Res. 2020.